These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34819571)

  • 1. Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathy.
    Tsukahara A; Hosokawa T; Nishioka D; Kotani T; Ishida S; Takeuchi T; Kimura F; Arawaka S
    Sci Rep; 2021 Nov; 11(1):22827. PubMed ID: 34819571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent diffusion coefficients distinguish amyotrophic lateral sclerosis from cervical spondylotic myelopathy.
    Koike Y; Kanazawa M; Terajima K; Watanabe K; Ohashi M; Endo N; Shimohata T; Nishizawa M
    Clin Neurol Neurosurg; 2015 May; 132():33-6. PubMed ID: 25746320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid levels of alpha-synuclein, amyloid β, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings.
    Katayama T; Sawada J; Kikuchi-Takeguchi S; Kano K; Takahashi K; Saito T; Okizaki A; Hasebe N
    Neurosci Lett; 2020 Jan; 715():134564. PubMed ID: 31733322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repetitive nerve stimulation as a diagnostic aid for distinguishing cervical spondylotic amyotrophy from amyotrophic lateral sclerosis.
    Zheng C; Jin X; Zhu Y; Lu F; Jiang J; Xia X
    Eur Spine J; 2017 Jul; 26(7):1929-1936. PubMed ID: 28364332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
    Gille B; De Schaepdryver M; Dedeene L; Goossens J; Claeys KG; Van Den Bosch L; Tournoy J; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1338-1346. PubMed ID: 31175169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of neuron-specific enolase in cerebrospinal fluid to predict neurological prognosis in cardiac arrest survivors who underwent target temperature management: A prospective observational study.
    You Y; Park JS; Min J; Yoo I; Ahn HJ; Cho Y; Ryu S; Lee J; Kim S; Cho S; Oh S; Jeong W; Kang C; Oh E; Lee IH; Lee B; Lee D; Youn CS
    Resuscitation; 2019 Dec; 145():185-191. PubMed ID: 31585184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value.
    Noto Y; Shibuya K; Sato Y; Kanai K; Misawa S; Sawai S; Mori M; Uchiyama T; Isose S; Nasu S; Sekiguchi Y; Fujimaki Y; Kasai T; Tokuda T; Nakagawa M; Kuwabara S
    Amyotroph Lateral Scler; 2011 Mar; 12(2):140-3. PubMed ID: 21126161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is cerebrospinal fluid obtained for diagnostic purpose a good material for biomarker studies in amyotrophic lateral sclerosis?
    Chełstowska B; Kuźma-Kozakiewicz M
    Biomarkers; 2014 Nov; 19(7):571-7. PubMed ID: 25133306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurospecific proteins in cerebrospinal fluid and in the bloodserum of patients with amyotrophic lateral sclerosis].
    Rushkevich YN; Pashkouskaya ID; Likhachev SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):75-80. PubMed ID: 29927408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
    Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
    Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.
    Steinacker P; Fang L; Kuhle J; Petzold A; Tumani H; Ludolph AC; Otto M; Brettschneider J
    PLoS One; 2011; 6(8):e23600. PubMed ID: 21858182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
    Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis.
    Li R; Wang J; Xie W; Liu J; Wang C
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1420-1428. PubMed ID: 32729234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Katayama T; Sawada J; Takahashi K; Yahara O; Hasebe N
    Alzheimers Res Ther; 2021 Oct; 13(1):163. PubMed ID: 34610837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity of Cervical Spondylogenic Myelopathy and Amyotrophic Lateral Sclerosis: When Electromyography Makes the Difference in Diagnosis.
    Torrieri MC; Monticelli M; Vasta R; Cofano F; Ajello M; Canosa A; Penner F; Marengo N; Manera U; Calvo A; Chiò A; Garbossa D; Moglia C
    Eur Neurol; 2020; 83(6):626-629. PubMed ID: 33296894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Chen X; Hu Y; Cao Z; Liu Q; Cheng Y
    Front Immunol; 2018; 9():2122. PubMed ID: 30283455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.
    Wuolikainen A; Jonsson P; Ahnlund M; Antti H; Marklund SL; Moritz T; Forsgren L; Andersen PM; Trupp M
    Mol Biosyst; 2016 Apr; 12(4):1287-98. PubMed ID: 26883206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
    Halbgebauer S; Steinacker P; Verde F; Weishaupt J; Oeckl P; von Arnim C; Dorst J; Feneberg E; Mayer B; Rosenbohm A; Silani V; Ludolph AC; Otto M
    J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):68-74. PubMed ID: 34417339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
    Grossman M; Elman L; McCluskey L; McMillan CT; Boller A; Powers J; Rascovsky K; Hu W; Shaw L; Irwin DJ; Lee VM; Trojanowski JQ
    JAMA Neurol; 2014 Apr; 71(4):442-8. PubMed ID: 24492862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid neurone-specific enolase in mitochondrial encephalomyopathies.
    Finsterer J; Exner M; Rumpold H
    Metab Brain Dis; 2005 Mar; 20(1):81-6. PubMed ID: 15918553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.